Acute Myeloid Leukemia Clinical Trial

Quality of Life Model for Older Patients With AML

Summary

The purpose of this study is to describe the differences in quality of life (QOL) among newly diagnosed patients diagnosed with acute myeloid leukemia (AML) to help design a patient decision-making QOL model for aligning patients' choice of treatment with what matters the most to them.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

60 years of age or older
Newly diagnosed with pathology-confirmed diagnosis of Acute Myeloid Leukemia
Within 7 days of starting a new treatment
Must be able to read and speak English at the 8th grade level

Exclusion Criteria:

Under 60 years of age
Other malignancy, dementia, traumatic brain injury or individuals with central nervous system involvement of their leukemia

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

220

Study ID:

NCT04380441

Recruitment Status:

Recruiting

Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Moffitt Cancer Center
Tampa Florida, 33612, United States More Info
Sara Tinsley, PhD, APRN
Contact
813-745-8000
[email protected]
Martine Extermann, MD, PhD
Sub-Investigator
Rami Komrokji, MD
Sub-Investigator
Andrew Kuykendall, MD
Sub-Investigator
Jeffrey Lancet, MD
Sub-Investigator
Eric Padron, MD
Sub-Investigator
David Sallman, MD
Sub-Investigator
Steve Sutton, PhD
Sub-Investigator
Kendra Sweet, MD
Sub-Investigator
Chetasi Talati, MD
Sub-Investigator
Michelle Jennings, PA-C
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

220

Study ID:

NCT04380441

Recruitment Status:

Recruiting

Sponsor:


H. Lee Moffitt Cancer Center and Research Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.